Evidence map›Paper›PMID 39276044›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2024

[Therapeutic mechanism of

G Yu, W Cheng, X Tu, M Zhang, H Li, J Nie

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

G YuChinese Medicinal Materials Products Quality Supervision and Inspection Center in Wuling Mountainous Area, Hubei Minzu University, Enshi 445000, China.
W ChengHealth Science Center, Hubei Minzu University, Enshi 445000, China.
X TuChinese Medicinal Materials Products Quality Supervision and Inspection Center in Wuling Mountainous Area, Hubei Minzu University, Enshi 445000, China.
M ZhangHealth Science Center, Hubei Minzu University, Enshi 445000, China.
H LiChinese Medicinal Materials Products Quality Supervision and Inspection Center in Wuling Mountainous Area, Hubei Minzu University, Enshi 445000, China.
J NieHealth Science Center, Hubei Minzu University, Enshi 445000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the targets and pathways of

methodsUPLC-QE-MS was used to identify the components of

resultsWe identified 240 chemical components in

conclusion

Indexed as

Colitis, UlcerativeCynanchumMetabolomicsMice, Inbred C57BLNetwork PharmacologyAnimalsChromatography, High Pressure LiquidDisease Models, AnimalDrugs, Chinese HerbalJanus Kinase 2MaleMicePlant ExtractsProtein Interaction MapsSTAT3 Transcription FactorDrugs, Chinese HerbalJanus Kinase 2Plant ExtractsStat3 protein, mouseSTAT3 Transcription FactorCynanchum wilfordii (Maxim.) Hook. Fmetabolomicssteroidsulcerative colitisUPLC-QE-MS

Identifiers

PMID39276044
PMCPMC11378042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.